Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) on Monday, plunged -0.77% from the previous trading day, before settling in for the closing price of $16.78. Within the past 52 weeks, TEVA’s price has moved between $9.35 and $19.31.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -2.68%. The company achieved an average annual earnings per share of -3.46%. With a float of $1.13 billion, this company’s outstanding shares have now reached $1.13 billion.
Let’s determine the extent of company efficiency that accounts for 37226 employees. In terms of profitability, gross margin is 49.87%, operating margin of 12.76%, and the pretax margin is -3.36%.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Insider Activity
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Teva- Pharmaceutical Industries Ltd. ADR is 0.01%, while institutional ownership is 56.95%. The most recent insider transaction that took place on Nov 20 ’24, was worth 327,085. In this transaction EVP, Head of U.S. Commercial of this company sold 19,388 shares at a rate of $16.87, taking the stock ownership to the 44,104 shares. Before that another transaction happened on Nov 20 ’24, when Company’s Officer proposed sale 19,388 for $16.87, making the entire transaction worth $327,085.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported 1 earnings per share (EPS) for the period topping the consensus outlook (set at 0.76) by 0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -3.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.24% during the next five years compared to 26.63% growth over the previous five years of trading.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Trading Performance Indicators
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) is currently performing well based on its current performance indicators. A quick ratio of 0.61 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.12. Likewise, its price to free cash flow for the trailing twelve months is 6.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.85, a number that is poised to hit 0.69 in the next quarter and is forecasted to reach 2.79 in one year’s time.
Technical Analysis of Teva- Pharmaceutical Industries Ltd. ADR (TEVA)
Looking closely at Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA), its last 5-days average volume was 8.37 million, which is a drop from its year-to-date volume of 9.2 million. As of the previous 9 days, the stock’s Stochastic %D was 45.98%. Additionally, its Average True Range was 0.42.
During the past 100 days, Teva- Pharmaceutical Industries Ltd. ADR’s (TEVA) raw stochastic average was set at 24.00%, which indicates a significant decrease from 37.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 19.66% in the past 14 days, which was lower than the 29.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.56, while its 200-day Moving Average is $16.27. However, in the short run, Teva- Pharmaceutical Industries Ltd. ADR’s stock first resistance to watch stands at $16.82. Second resistance stands at $17.00. The third major resistance level sits at $17.12. If the price goes on to break the first support level at $16.52, it is likely to go to the next support level at $16.40. Should the price break the second support level, the third support level stands at $16.22.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Key Stats
Market capitalization of the company is 18.86 billion based on 1,132,909K outstanding shares. Right now, sales total 15,846 M and income totals -559,000 K. The company made 4,332 M in profit during its latest quarter, and -437,000 K in sales during its previous quarter.
